For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

Institute of Cancer Research

Return to search Previous output Next output
Output 15 of 298 in the submission
Article title

A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors

Type
D - Journal article
Title of journal
CLIN CANCER RES
Article number
-
Volume number
17
Issue number
6
First page of article
1561
ISSN of journal
1078-0432
Year of publication
2011
URL
-
Number of additional authors
15
Additional information
-
Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
50
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-